T CELL RECEPTOR SIGNALING BY PHOSPHORYLATED FORMS OF TCR
T 细胞受体信号传导(磷酸化 TCR 形式)
基本信息
- 批准号:6362348
- 负责人:
- 金额:$ 22.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-03-01 至 2004-02-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from Investigator's Abstract): The T cell receptor
(TCR) zeta subunit, a component of the TCR complex, plays a critical
role in TCR-mediated signal transduction. Following TCR engagement, the
TCR-zeta subunit is phosphorylated on multiple tyrosine residues,
resulting in the formation of two phosphorylated forms of 21 and 23 kDa.
Recent studies have provided correlative evidence that the specific
types of TCR zeta forms differ in their ability to couple to downstream
effector molecules. Such differences are proposed to influence the
processes of T cell development, the types of cytokines secreted by the
T cells, and contribute to T cell anergy. The overall goal of this
proposal is to understand how the formation of the 21 and 23 kDa
phosphorylated species of the TCR zeta subunit affects TCR-mediated
responses. The functional contribution of these phosphorylated forms of
TCR zeta will be determined by selectively eliminating the formation of
one or the other form in T cells and assessing the effects of these
modifications on T cell development, TCR-mediated signal transduction,
and T cell energy induction. Characterizing the regulation of TCR zeta
phosphorylation, ZAP-70 recruitment and activation, and the interaction
of the 21 and 23 kDa phosphorylated forms of TCR zeta with additional
effector molecules is vital to our understanding of how these
phosphorylated forms function during normal and pathological processes.
The information derived from the proposed studies will have implications
in regulating immune responses during T cell development, autoimmune
diseases, allergic responses, and viral modulation of immune cells.
描述(改编自研究者摘要):T细胞受体
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NICOLAI Stanislas Cyrille VAN OERS其他文献
NICOLAI Stanislas Cyrille VAN OERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NICOLAI Stanislas Cyrille VAN OERS', 18)}}的其他基金
Coding and Noncoding RNA Contributions to 22q11.2 Deletion Syndrome
编码和非编码 RNA 对 22q11.2 缺失综合征的贡献
- 批准号:
10442758 - 财政年份:2015
- 资助金额:
$ 22.68万 - 项目类别:
Long noncoding RNAs and their contribution to 22q11.2 deletion syndrome
长非编码 RNA 及其对 22q11.2 缺失综合征的贡献
- 批准号:
9089900 - 财政年份:2015
- 资助金额:
$ 22.68万 - 项目类别:
Coding and Noncoding RNA Contributions to 22q11.2 Deletion Syndrome
编码和非编码 RNA 对 22q11.2 缺失综合征的贡献
- 批准号:
10206036 - 财政年份:2015
- 资助金额:
$ 22.68万 - 项目类别:
Coding and Noncoding RNA Contributions to 22q11.2 Deletion Syndrome
编码和非编码 RNA 对 22q11.2 缺失综合征的贡献
- 批准号:
10641854 - 财政年份:2015
- 资助金额:
$ 22.68万 - 项目类别:
MicroRNA Profiling of Pediatric Immunodeficiency Patients
儿童免疫缺陷患者的 MicroRNA 分析
- 批准号:
7707193 - 财政年份:2009
- 资助金额:
$ 22.68万 - 项目类别:
MicroRNA Profiling of Pediatric Immunodeficiency Patients
儿童免疫缺陷患者的 MicroRNA 分析
- 批准号:
7934643 - 财政年份:2009
- 资助金额:
$ 22.68万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 22.68万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 22.68万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 22.68万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 22.68万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 22.68万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 22.68万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 22.68万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 22.68万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 22.68万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 22.68万 - 项目类别:
Discovery Grants Program - Individual